Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 1

2(50.0%)

Phase 4

1(25.0%)

N/A

1(25.0%)

4Total

Phase 1(2)

Phase 4(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT04584125Not ApplicableNot Yet Recruiting

A Randomized Clinical Trial of Ex Vivo Corneal Cross-Linking of Donor Keratoplasty Tissue for Keratoconus Used for Keratoplasty in Keratoconus Patients

Role: lead

NCT02863809Phase 1Completed

Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit

Role: lead

NCT01582880Phase 1Completed

Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis

Role: lead

NCT02256969Phase 4Completed

Intraductal Meibomian Gland Probing Trial

Role: lead

All 4 trials loaded